From: Gender differences in subjective discontinuation symptoms associated with ketamine use
 |  | Total | Male | Female | AORsc | P value | 95% CI |
---|---|---|---|---|---|---|---|
Cognitive impairment | Nil | 23.9% | 24.7% | 20.2% | reference | - | - |
mild | 53.6% | 53.9% | 52.3% | 1.275 | 0.258 | 0.837-1.942 | |
severe | 22.4% | 21.4% | 27.5% | 1.717 | 0.024* | 1.075-2.741 | |
Urinary tract symptoms | Nil | 49.5% | 49.7% | 48.4% | reference | - | - |
milda | 45.8% | 46.5% | 41.9% | 0.915 | 0.601 | 0.656-1.276 | |
severeb | 4.8% | 3.8% | 9.7% | 2.719 | 0.001** | 1.501-4.928 |